GABA is the strangest resident of the sleep aisle: it’s the brain’s own inhibitory neurotransmitter, sold as a pill — and science is still arguing about whether the pill can reach the brain at all (PMID 26500584). We read 524 GABA-containing products from the NIH label database to see what a shelf does with an ingredient whose basic question is unresolved.
The answer: it never agreed on anything — least of all the dose.
A three-thousand-fold spread
Stated GABA doses in our sample run from 1 mg — token amounts in multivitamins — to 3,000 mg in sports powders. Median: 200 mg. And the distribution isn’t a bell curve; it’s two separate camps:
- 100–250 mg — 159 products: the modern sleep-and-calm convention.
- 500–750 mg and up — 130 products: the old bodybuilding tradition, where multi-gram GABA was sold for growth-hormone spikes long before the sleep aisle adopted it. The 3,000 mg products in our data are named things like “GH-Boost” and “Knockout”.
Same ingredient, same database, two dosing cultures an order of magnitude apart — because no trial ever settled what a dose of GABA is.
402 dosed GABA labels · NIH database
Two dosing camps, an order of magnitude apart
Stated GABA per serving. Gold rows are the two camps.
The valley between the camps is the story. 100–250 mg descends from manufacturer-run sleep studies; 500 mg+ from bodybuilding folklore. Only 4.8% of products name the branded form the studies actually used.
The evidence, such as it is
The human sleep study most often cited for GABA reported shorter sleep latency and more non-REM sleep after oral GABA (PMID 30263304). Read the author line: every author is affiliated with Pharma Foods International — the company that makes PharmaGABA, the branded ingredient. That doesn’t make the result false; it makes it a manufacturer’s result awaiting independent replication, which a buyer deserves to know.
Meanwhile, a peer-reviewed review of the field put the core problem plainly: whether oral GABA crosses the blood-brain barrier in meaningful amounts is still an open question — with the interesting wrinkle that some observed effects might route through the gut instead (PMID 26500584).
And here’s our label count against that backdrop: only 4.8% of GABA products name the branded, actually-studied form. The other 95% sell generic GABA at doses inherited from one of the two camps — while 23.3% hide the dose in a blend altogether.
The dilution effect, ninth replication
Dedicated GABA products: median 500 mg. The same ingredient inside someone else’s sleep formula: median 100 mg — a five-fold drop, the steepest we’ve measured since ashwagandha. Nine ingredients now, nine replications, zero exceptions.
Where we stand
GABA is on our published list of rejected ingredients — we passed on it precisely because the brain-delivery question is unresolved and the strongest human data is manufacturer-run. This count flatters that decision; weigh accordingly. The dataset is public.
Limits: the sample is the 600 most relevant of 1,134 database records (524 with GABA in the panel); one sub-milligram formula listing was excluded from the range statement; doses are per serving as printed; the two-camp split is our reading of a clearly bimodal distribution, and the camp boundaries (250/500) are round-number choices, not natural law.
How to read a GABA label in ten seconds
- Ask which camp the number is from. 100–200 mg descends from the manufacturer-run sleep studies; 750 mg+ descends from bodybuilding folklore. Neither has independent confirmation behind it.
- If the label says PharmaGABA, you’re at least holding the form the studies used — one product in twenty does.
- Know the open question. Whether swallowed GABA reaches the brain is genuinely undecided. Any label implying certainty is ahead of the science.
How we counted, so you can check us
We searched the DSLD for “GABA”, took the 600 most relevant on-market records, and read 526 full labels on 30 August 2026; 524 list GABA in the supplement facts panel. Doses were read from the GABA line (blends walked, units converted, per serving as printed); top and bottom doses were verified by hand against their labels. Both cited papers are linked with their PubMed records; the manufacturer affiliation is taken from the paper’s own author-information field.
The database is free and needs no account. If you repeat this and get different numbers, we’d like to know.
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is educational and is not medical advice; if you have a medical condition or take medication, talk to your healthcare provider.